In order to bridge the gap between cell lines and Pan-cancer tumor samples, we extracted the BRCA samples and compared the TCI-predicted PIK3CA target DEGs in breast cancer tumors with that from Hart’s study. This evidence concerns the gene PIK3CA and neoplasm.